Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Listerine "smart" about kids: Smart Rinse provides visual cues to help children see the benefit of oral care, Johnson & Johnson says March 11. The newly launched anticavity fluoride rinse for kids tints particles in the mouth after brushing and flossing to show what is left behind. A J&J-funded survey found that "not brushing teeth" was cited by 49 percent of parents as their child's worst habit, and 77 percent of parents polled say they wish there was "a fun way to teach better oral care," the firm says. "Listerine Smart Rinse was designed with fun and functionality in mind and helps to extend Johnson & Johnson's legacy of building and innovating brands that moms can depend on," says Kathleen Weber, VP for oral care at J&J subsidiary McNeil-PPC, Inc. Smart Rinse is offered in two flavors - Mint Shield and Berry Shield - and is available in food, drug and mass doors for $3.99 to $4.89...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel